521
Views
34
CrossRef citations to date
0
Altmetric
Original

CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells

, , , , , , , & show all
Pages 2218-2223 | Received 04 Jun 2005, Accepted 04 Mar 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Laura Escribà-Garcia, Carmen Alvarez-Fernández, Ana Carolina Caballero, Robert Schaub, Jorge Sierra & Javier Briones. (2019) The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma. OncoImmunology 8:2.
Read now
Masood A. Khan, Ahmed N. Aljarbou, Yousef H. Aldebasi, Mohammed S. Alorainy, Arshad H. Rahmani, Hina Younus & Arif Khan. (2018) Liposomal formulation of glycosphingolipids from Sphingomonas paucimobilis induces antitumour immunity in mice. Journal of Drug Targeting 26:8, pages 709-719.
Read now

Articles from other publishers (31)

Alex Look, Daniel Burns, Ivo Tews, Ali Roghanian & Salah Mansour. (2023) Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes. Frontiers in Immunology 14.
Crossref
Juan Esteban Garcia-Robledo, Oscar Arrieta, Camila Ordoñez, Andrés Mosquera & Andrés F. Cardona. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma 515 538 .
Farbod Ghobadinezhad, Zhila Izadi, Marzieh Ebrahimi & Rezaei Nima. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 25 .
Hashem Bayatipoor, Saber Mehdizadeh, Roghayeh Jafarpour, Zeinab Shojaei, Salar Pashangzadeh & Morteza Motallebnezhad. (2022) Role of NKT cells in cancer immunotherapy—from bench to bed. Medical Oncology 40:1.
Crossref
Kimberly A. Luddy, Jamie K. Teer, Audrey Freischel, Cliona O’Farrelly & Robert Gatenby. (2022) Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes. Frontiers in Genetics 13.
Crossref
Song-Yang Wu, Tong Fu, Yi-Zhou Jiang & Zhi-Ming Shao. (2020) Natural killer cells in cancer biology and therapy. Molecular Cancer 19:1.
Crossref
Takahiro Aoki, Mariko Takami, Tomozumi Takatani, Kiwamu Motoyoshi, Ayana Ishii, Ayaka Hara, Takahide Toyoda, Reona Okada, Moeko Hino, Ryo Koyama‐Nasu, Masahiro Kiuchi, Kiyoshi Hirahara, Motoko Y. Kimura, Toshinori Nakayama, Naoki Shimojo & Shinichiro Motohashi. (2020) Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner. Cancer Science 111:7, pages 2223-2233.
Crossref
Nishant P. Patel, Peng Guan, Devika Bahal, Tanwir Hashem, Felix Scheuplein, Robert Schaub, Kim E. Nichols & Rupali Das. (2020) Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody. International Journal of Molecular Sciences 21:12, pages 4317.
Crossref
Yingting Zhang, Ryan Springfield, Siyang Chen, Xin Li, Xiaotian Feng, Rosa Moshirian, Rirong Yang & Weiming Yuan. (2019) α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials. Frontiers in Immunology 10.
Crossref
Rajkumar Noubade, Sonia Majri-Morrison & Kristin V. Tarbell. (2019) Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity. Frontiers in Immunology 10.
Crossref
Siddhartha Srivastava, Christina Jackson, Timothy Kim, John Choi & Michael Lim. (2019) A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials. Cancers 11:4, pages 537.
Crossref
Rupali DasPeng GuanSusan J. WienerNishant P. PatelTrevor G. GohlElizabeth Evans, Maurice Zauderer & Kim E. Nichols. (2019) Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein. Blood Advances 3:5, pages 813-824.
Crossref
Rein Verbeke, Ine Lentacker, Karine Breckpot, Jonas Janssens, Serge Van Calenbergh, Stefaan C. De Smedt & Heleen Dewitte. (2019) Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells. ACS Nano.
Crossref
Katharina Kriegsmann, Mark Kriegsmann, Michael von Bergwelt-Baildon, Martin Cremer & Mathias Witzens-Harig. (2018) NKT cells - New players in CAR cell immunotherapy?. European Journal of Haematology 101:6, pages 750-757.
Crossref
Daniëlle Krijgsman, Marianne Hokland & Peter J. K. Kuppen. (2018) The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach. Frontiers in Immunology 9.
Crossref
Amrendra Kumar, Naveenchandra Suryadevara, Timothy M. Hill, Jelena S. Bezbradica, Luc Van Kaer & Sebastian Joyce. (2017) Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective. Frontiers in Immunology 8.
Crossref
Pui Yeng Lam, Michael D. Nissen & Stephen R. Mattarollo. (2017) Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies. Frontiers in Immunology 8.
Crossref
Shiny Nair & Madhav V. Dhodapkar. (2017) Natural Killer T Cells in Cancer Immunotherapy. Frontiers in Immunology 8.
Crossref
Maureen Banach & Jacques Robert. (2017) Tumor Immunology Viewed from Alternative Animal Models—the Xenopus Story. Current Pathobiology Reports 5:1, pages 49-56.
Crossref
Susannah C. Shissler, Dominique R. Bollino, Irina V. Tiper, Joshua P. Bates, Roshanak Derakhshandeh & Tonya J. Webb. (2016) Immunotherapeutic strategies targeting natural killer T cell responses in cancer. Immunogenetics 68:8, pages 623-638.
Crossref
Zaigham Abbas Rizvi, Niti Puri & Rajiv K. Saxena. (2015) Lipid antigen presentation through CD1d pathway in mouse lung epithelial cells, macrophages and dendritic cells and its suppression by poly-dispersed single-walled carbon nanotubes. Toxicology in Vitro 29:6, pages 1275-1282.
Crossref
Agnieszka Bojarska-Junak, Iwona Hus, Sylwia Chocholska, Waldemar Tomczak, Justyna Woś, Paweł Czubak, Lechosław Putowski & Jacek Roliński. (2014) CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis. Leukemia Research 38:4, pages 435-442.
Crossref
Martin Wilhelm, Manfred Smetak, Kerstin Schaefer-Eckart, Brigitte Kimmel, Josef Birkmann, Hermann Einsele & Volker Kunzmann. (2014) Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells. Journal of Translational Medicine 12:1, pages 45.
Crossref
Ghasem Ghalamfarsa, Abolghasem Hadinia, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2013) The role of natural killer T cells in B cell malignancies. Tumor Biology 34:3, pages 1349-1360.
Crossref
Farhad Jadidi-Niaragh, Mahmood Jeddi-Tehrani, Bita Ansaripour, Seyed Mohsen Razavi, Ramazan Ali Sharifian & Fazel Shokri. (2012) Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia. Medical Oncology 29:5, pages 3561-3569.
Crossref
Natalia Neparidze & Madhav V. Dhodapkar. 2012. Natural Killer T cells. Natural Killer T cells 153 167 .
Jianyun Liu, Gourapura J. Renukaradhya & Randy R. Brutkiewicz. 2012. Natural Killer T cells. Natural Killer T cells 71 94 .
Laura M. Hix, Yihui H. Shi, Randy R. Brutkiewicz, Paul L. Stein, Chyung-Ru Wang & Ming Zhang. (2011) CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis. PLoS ONE 6:6, pages e20702.
Crossref
Gerhard Wingender, Philippe Krebs, Bruce Beutler & Mitchell Kronenberg. (2010) Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency. The Journal of Immunology 185:5, pages 2721-2729.
Crossref
Liping Song, Shahab Asgharzadeh, Jill Salo, Kelly Engell, Hong-wei Wu, Richard Sposto, Tasnim Ara, Ayaka M. Silverman, Yves A. DeClerck, Robert C. Seeger & Leonid S. Metelitsa. (2009) Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. Journal of Clinical Investigation 119:6, pages 1524-1536.
Crossref
Gourapura J. Renukaradhya, Masood A. Khan, Marcus Vieira, Wenjun Du, Jacquelyn Gervay-Hague & Randy R. Brutkiewicz. (2008) Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. Blood 111:12, pages 5637-5645.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.